Literature DB >> 3929922

The low dose aspirin controversy solved at last?

R D Eastham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929922      PMCID: PMC1416647          DOI: 10.1136/bmj.291.6497.738-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  7 in total

1.  Cumulative antiplatelet effect of low-dose enteric coated aspirin.

Authors:  J A Jakubowski; M J Stampfer; R Vaillancourt; D Deykin
Journal:  Br J Haematol       Date:  1985-08       Impact factor: 6.998

2.  Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.

Authors:  G de Gaetano; C Cerletti; V Bertelè
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

3.  Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins.

Authors:  H Sinzinger; J O'Grady; P Fitscha; J Kaliman
Journal:  N Engl J Med       Date:  1984-10-18       Impact factor: 91.245

4.  Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation.

Authors:  J Merino; M Livio; G Rajtar; G de Gaetano
Journal:  Biochem Pharmacol       Date:  1980-04-15       Impact factor: 5.858

5.  Possible significance of small numbers of functional platelets in a population of aspirin-treated platelets in vitro and in vivo.

Authors:  A L Cerskus; M Ali; B J Davies; J W McDonald
Journal:  Thromb Res       Date:  1980 May 1-15       Impact factor: 3.944

6.  Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis.

Authors:  S P Hanley; J Bevan; S R Cockbill; S Heptinstall
Journal:  Lancet       Date:  1981-05-02       Impact factor: 79.321

7.  Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.

Authors:  A K Pedersen; G A FitzGerald
Journal:  N Engl J Med       Date:  1984-11-08       Impact factor: 91.245

  7 in total
  1 in total

1.  Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats.

Authors:  Basma K Ramadan; Mona F Schaalan; Amina M Tolba
Journal:  BMC Complement Altern Med       Date:  2017-01-11       Impact factor: 3.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.